Amgen reported $2.49B in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -63.47M 6.06M
Agios Pharmaceuticals AGIO:US $ -90.88M 6.78M
Amgen AMGN:US $ 2489M 145M
Biogen BIIB:US $ 966.2M 156.7M
Bluebird Bio BLUE:US $ -205.74M 6.12M
Bristol Myers Squibb BMY:US $ 4761M 820M
Eli Lilly And LLY:US $ 1908M 1024.6M
Genmab GEN:DC DK 1424M 873M
GlaxoSmithKline GSK:LN 1707M 129M
Glaxosmithkline GSK:US $ 2353.61M 268.5M
Intercept Pharmaceuticals ICPT:US $ -40.42M 11.73M
IONIS PHARMACEUT IONS:US $ -83M 149M
Johnson & Johnson JNJ:US $ 8291M 2690M
Merk MRK:US $ 4149M 192M
Mirati Therapeutics MRTX:US $ -135.68M 34.59M
Moderna Inc MRNA:US 1.26B 1.53B
Neurocrine Biosciences NBIX:US $ 27.2M 32.9M
Novartis NOVN:VX SF 3804M 295M
Novartis NVS:US $ 3804M 295M
Pfizer PFE:US $ 6225M 3560M
Ptc Therapeutics PTCT:US $ -128.19M 66.47M
Sanofi SAN:FP € 2556M 594M
Sarepta Therapeutics SRPT:US $ -167.39M 21.09M
Teva Pharmaceutical TEVA:IT 144M 761M
Ultragenyx Pharmaceutical RARE:US $ -135.76M 111.82M